IMDZ News and Press, Immune Design Corp. From 02/22/19

HENDERSON, NV / ACCESSWIRE / February 22, 2019 / Below are several healthcare companies in the news leading the sector recently. A company in the sector that has not had news recently but according to their website, "has an open IND (Investigational New Drug) and has agreed with the FDA on a...

Alexion Pharmaceuticals (NASDAQ: ALXN ) initiated with Neutral rating and $135 (6% upside) price target at Guggenheim. More news on: Alexion Pharmaceuticals, Inc., Dermira, Exelixis, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Gainers:  Immune Design (NASDAQ: IMDZ ) +310% . Zosano Pharma Corporation (NASDAQ: ZSAN ) +121% . Adial Pharmaceuticals (NASDAQ: ADIL ) +21% . Grand Canyon Education (NASDAQ: LOPE ) +21% . Attunity (NASDAQ: ATTU ) +19% . Career Education (NASDAQ: CECO ) +18% . Avis Budget Group ...

Immune Design (NASDAQ: IMDZ ) +312%  on being acquired by Merck. More news on: Immune Design, Sequans Communications, Community Health Systems, Inc., Stocks on the move, Read more ...

CORAL GABLES, FL / ACCESSWIRE / February 21, 2019 / The recent success of the healthcare stock market can be attributed to the fact that companies in the healthcare industry are looking into new innovative approaches and technologies to better improve their offerings for consumers. Whereas...

Acquisition Bolsters Capabilities in Vaccine Development for Infectious Diseases and Cancer Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Immune Design (NASDAQ:IMDZ), today announced that the companies have entered into a definitive agreement under which Mer...